scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1022819336 |
P356 | DOI | 10.2165/00148581-200507040-00002 |
P698 | PubMed publication ID | 16117559 |
P2093 | author name string | Chrysanthi L Skevaki | |
Dimitrios A Kafetzis | |||
P2860 | cites work | Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues | Q26342655 |
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project | Q28145755 | ||
Tuberculosis in the newborn: an emerging disease | Q30429195 | ||
Infants 12 month-old or less as a high risk group in tuberculosis--comparison of clinical data with those in children aged one to two years | Q30656074 | ||
The safety of antituberculosis medications during breastfeeding | Q33595131 | ||
Tuberculosis in infants less than 3 months of age | Q33623873 | ||
Treatment of tuberculous infection and disease in children: the North American perspective | Q33997764 | ||
Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells | Q34082942 | ||
Controlling tuberculosis in India | Q34157120 | ||
Congenital tuberculosis. Review and diagnostic guidelines | Q34197605 | ||
Congenital tuberculosis presenting as sepsis syndrome: case report and review of the literature | Q34238465 | ||
Management of tuberculosis in the United States | Q34313455 | ||
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention | Q34340511 | ||
Global tuberculosis incidence and mortality during 1990-2000. | Q34728126 | ||
Therapeutic drug monitoring in the treatment of tuberculosis | Q34967044 | ||
Childhood tuberculosis: treatment strategies and recent advances | Q35046626 | ||
Adenosine deaminase and interferon gamma measurements for the diagnosis of tuberculous pleurisy: a meta-analysis | Q35200811 | ||
Extra-pulmonary tuberculosis in children | Q35267671 | ||
Tuberculosis and pregnancy. | Q35654034 | ||
Diagnostic tools in tuberculous pleurisy: a direct comparative study: 1 | Q38464104 | ||
Conservative treatment of tuberculosis of the thoracic and lumbar spine in adults and children | Q38535633 | ||
Tuberculosis in children and adolescents | Q38688372 | ||
Tuberculosis in children and its management. | Q38734848 | ||
[Thoracic standard radiology and x-ray computed tomography in mediastino-pulmonary tuberculosis in infants] | Q71513805 | ||
[Tuberculous osteitis in infants] | Q71763460 | ||
Effect of preparation method and storage on rifampin concentration in suspensions | Q72397692 | ||
American Academy of Pediatrics. Committee on Infectious Diseases: Screening for tuberculosis in infants and children | Q72667684 | ||
Sonographic diagnosis of congenital tuberculosis: an experience with four cases | Q73071218 | ||
[Difficulties in the treatment of tuberculosis in infants] | Q73169584 | ||
Congenital tuberculosis manifesting as cutaneous disease | Q73250361 | ||
Isoniazid acetylation metabolic ratio during maturation in children | Q73846460 | ||
Local immune responses correlate with presentation and outcome in tuberculosis | Q74363365 | ||
Diagnosis of pediatric tuberculosis in the modern era | Q74523392 | ||
Effectiveness of short-course, intermittent chemotherapy for tuberculosis in young infants aged less than 6 months | Q74802241 | ||
Tuberculosis in the neonatal period | Q74805467 | ||
Molecular action of anti-mycobacterial agents | Q74841700 | ||
A Prospective Study of Bacillus Calmette-Guérin Scar Formation and Tuberculin Skin Test Reactivity in Infants in Lima, Peru | Q79108006 | ||
Congenital tuberculosis | Q83331970 | ||
Hepatotoxic reactions in children with severe tuberculosis treated with isoniazid-rifampin | Q93560255 | ||
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial | Q38888213 | ||
Modern approach to the diagnosis and treatment of tuberculosis in children | Q39643310 | ||
The management of tuberculosis during pregnancy | Q39954374 | ||
Cytokine-based approaches to the treatment of multidrug-resistant tuberculosis | Q40151704 | ||
Should women taking antituberculosis drugs breast-feed? | Q40171981 | ||
Congenital tuberculosis: critical reappraisal of clinical findings and diagnostic procedures | Q40366685 | ||
Tuberculosis during infancy | Q40621360 | ||
Central nervous system tuberculosis in infants and children | Q40709157 | ||
Tuberculosis in pregnancy with fatal congenital infection | Q40856301 | ||
Tuberculosis. An old disease but a new threat to the mother, fetus, and neonate | Q41429353 | ||
Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature | Q41688416 | ||
Pulmonary tuberculosis--usual and unusual radiographic presentations | Q41760634 | ||
Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis | Q41874546 | ||
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol | Q42657080 | ||
Incidence of childhood tuberculosis after neonatal BCG vaccination | Q42664474 | ||
Multiple intracranial tuberculomas in infancy | Q43741603 | ||
Treatment of childhood tuberculosis with a six month directly observed regimen of only two weeks of daily therapy | Q43882618 | ||
Tuberculosis (presumed congenital) in a neonatal unit in Dar-es-Salaam, Tanzania | Q43950948 | ||
Neonatal tuberculosis associated with shock, disseminated intravascular coagulation, hemophagocytic syndrome, and hypercalcemia: a case report. | Q44295879 | ||
Combined use of the polymerase chain reaction and detection of adenosine deaminase activity on pleural fluid improves the rate of diagnosis of pleural tuberculosis. | Q44582275 | ||
[Tuberculosis in children]. | Q44708812 | ||
Comparison of six biological markers for the diagnosis of tuberculous pleuritis | Q44790531 | ||
A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis. | Q45224944 | ||
The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection | Q45771402 | ||
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic | Q46228076 | ||
Twice weekly vs. daily chemotherapy for childhood tuberculosis. | Q46246029 | ||
Clinical features, diagnosis, and treatment of tuberculosis in infants | Q46257176 | ||
Polymerase chain reaction to detect Mycobacterium tuberculosis in histologic specimens | Q47329782 | ||
Congenital tuberculosis proven by percutaneous liver biopsy: report of a case. | Q51696968 | ||
Congenital tuberculosis associated with maternal asymptomatic endometrial tuberculosis. | Q51713403 | ||
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature | Q52877396 | ||
Congenital spine tuberculosis: early diagnosis by imaging studies. | Q53650189 | ||
Predominant location of pulmonary parenchymal lesions of tuberculosis primary complex in infants aged less than one year | Q53652936 | ||
Pulmonary tuberculosis in five young infants with nursery exposure: clinical, radiographic and CT findings. | Q53713096 | ||
Neopterin levels and pulmonary tuberculosis in infants. | Q54129910 | ||
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. | Q54135989 | ||
Clinical and immune responses of tuberculosis patients treated with low-dose IL-2 and multidrug therapy. | Q54162721 | ||
Antituberculous agents. Isoniazid, rifampin, streptomycin, ethambutol, and pyrazinamide. | Q54499351 | ||
Congenital tuberculous lymphadenitis in a preterm infant in Greece | Q54775414 | ||
Miliary Tuberculosis in Children: A Clinical Review | Q58003715 | ||
Brief report: congenital tuberculosis | Q64135458 | ||
Intensive short course chemotherapy for treatment of Greek children with tuberculosis | Q67601039 | ||
PPD skin test conversion in health-care workers after exposure to Mycobacterium tuberculosis infection in infants | Q68319154 | ||
Acetylation phenotype and hepatotoxicity in the treatment of tuberculosis in children | Q68799188 | ||
Hepatic function in relation to acetylator phenotype in children treated with antitubercular drugs | Q69453088 | ||
A case-control study to evaluate the effectiveness of mass neonatal BCG vaccination among Canadian Indians | Q69536055 | ||
Short course chemotherapy for tuberculosis in children | Q69798886 | ||
Pyridoxine deficiency in children treated with isoniazid | Q70086562 | ||
Congenital tuberculosis | Q70575267 | ||
Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis | Q70992665 | ||
Short-course chemotherapy for tuberculosis in children | Q70997893 | ||
The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices | Q71002802 | ||
Management of tuberculin reactors in children and adolescents previously vaccinated with BCG | Q71153035 | ||
P433 | issue | 4 | |
P921 | main subject | tuberculosis | Q12204 |
P304 | page(s) | 219-234 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Pediatric Drugs | Q15767256 |
P1476 | title | Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues | |
P478 | volume | 7 |